The Chemours Company (CC) on Tuesday reported first-quarter results with revenue edging higher from last year, while losses widened amid higher costs.
The company posted net sales of $1.38 billion for the three months ended March 31, 2026, compared with $ 1.36 billion a year earlier. Net loss widened to $29 million from $5 million in the prior-year quarter.
Gross profit declined to $212 million from $236 million last year, while total other operating expenses were $186 million compared with $183 million.
Selling, general and administrative expenses rose to $147 million from $123 million, while research and development expenses were $26 million versus $27 million a year ago.
Looking ahead, Chemours expects second-quarter net sales to increase 15 percent to 20 percent sequentially, with adjusted EBITDA projected between $220 million and $250 million.
Loss per share was $0.19 for the quarter, compared with a loss of $0.03 per share in the same period last year.
CC is currently trading after hours at $27.15, down $0.79 or 2.83 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.